# Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

> **NCT00184054** · PHASE2 · TERMINATED · sponsor: **University of Southern California** · enrollment: 11 (actual)

## Conditions studied

- Acute Myelogenous Leukemia

## Interventions

- **DRUG:** Arsenic Trioxide (ATO)
- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT00184054
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-04
- **Primary completion:** 2009-06
- **Final completion:** 2011-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Competing studies
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184054, "Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00184054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*